Gene One Life Science to repurchase KRW 2.6 billion of debt early on bondholder put option exercise
Bitget2026/10/07 10:02Gene One Life Science set an early repurchase of KRW 2.5 billion of its 6th private convertible bonds. Total cash outlay set at KRW 2.6 billion, reflecting principal and interest; payment scheduled for Nov. 4, 2026. Transaction triggered by a bondholder put option; repurchase to be funded from internal cash. Bonds carry a conversion price of KRW 10,960; full conversion would issue 228,102 common shares, equal to 1.25%. Outstanding principal balance expected to fall to KRW 500 million following the buyback. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gene One Life Science Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261007000497), on October 07, 2026, and is solely responsible for the information contained therein.
- Gene One Life Science set an early repurchase of KRW 2.5 billion of its 6th private convertible bonds.
- Total cash outlay set at KRW 2.6 billion, reflecting principal and interest; payment scheduled for Nov. 4, 2026.
- Transaction triggered by a bondholder put option; repurchase to be funded from internal cash.
- Bonds carry a conversion price of KRW 10,960; full conversion would issue 228,102 common shares, equal to 1.25%.
- Outstanding principal balance expected to fall to KRW 500 million following the buyback.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pendle Bridge integrates with BungeeExchange, supporting cross-chain transfers across 13 networks
Barclays significantly increased holdings in Tesla (TSLA.US) and Intel (INTC.US) in Q3, and bought Nasdaq ETF options for hedging
According to disclosures by the U.S. Securities and Exchange Commission (SEC), Barclays has submitted its third-quarter holdings report (13F) as of September 30, 2026.
SNT Holdings, Related Party Raise Combined Stake in SNTEnergy to 55.75% From 52.75%
Crypto prices
More
